Wall Street Analysts Predict a 52.64% Upside in Avita Medical (RCEL): Here's What You Should Know

Group 1 - Avita Medical Inc. (RCEL) shares have increased by 20.5% in the past four weeks, closing at $10.22, with a mean price target of $15.60 indicating a potential upside of 52.6% [1] - The average price targets from analysts range from a low of $11 to a high of $21, with a standard deviation of $3.71, suggesting a variability in estimates [2] - Analysts show a consensus that RCEL will report better earnings than previously estimated, which is a positive indicator for potential stock upside [4][9] Group 2 - The Zacks Consensus Estimate for RCEL has increased by 30% due to two upward revisions in earnings estimates over the last 30 days, with no negative revisions [10] - RCEL holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for near-term upside [11] - While consensus price targets may not be reliable for predicting exact stock gains, they can provide a directional guide for price movement [12]